| |
| |
|
| Insider
Information: |
Carroll J Martin |
| Relationship: |
Director |
| City: |
Ridgefield |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
206,585 |
|
|
Indirect Shares
|
11,663 |
|
|
| Direct
Value |
$2,130,966 |
|
|
|
Indirect Value
|
$659,309 |
|
|
| Total
Shares |
218,248 |
|
|
| Total
Value |
$2,790,275 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 31.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vivus Inc |
VVUS |
Director |
2013-05-09 |
20,000 |
2013-05-09 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2021-03-12 |
0 |
2021-03-12 |
0 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Director |
2021-08-10 |
106,864 |
2015-05-08 |
0 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
28,071 |
2022-10-27 |
11,663 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
Director |
2016-05-13 |
10,000 |
2016-05-13 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
41,650 |
2022-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-30 |
4 |
D |
$9.19 |
$96,964 |
I/I |
(10,551) |
0 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2019-07-15 |
4 |
D |
$53.24 |
$262,313 |
I/I |
(4,927) |
0 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2020-05-12 |
4 |
D |
$72.29 |
$260,244 |
I/I |
(3,600) |
0 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2021-03-12 |
4 |
S |
$0.40 |
$12,581 |
I/I |
(31,398) |
0 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2021-03-12 |
4 |
S |
$0.40 |
$4,274 |
D/D |
(10,667) |
0 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2013-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,034 |
3,034 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2020-05-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,600 |
3,600 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2015-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,928 |
|
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2019-07-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,927 |
4,927 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2019-07-15 |
4 |
A |
$53.24 |
$262,313 |
I/I |
4,927 |
4,927 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2022-06-02 |
4 |
B |
$5.64 |
$28,180 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2013-11-26 |
4 |
B |
$51.27 |
$102,540 |
D/D |
2,000 |
5,034 |
2.39 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2014-03-20 |
4 |
D |
$69.95 |
$67,921 |
D/D |
(971) |
6,637 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2015-09-04 |
4 |
A |
$27.26 |
$81,780 |
D/D |
3,000 |
6,928 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
572 |
7,209 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2014-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,574 |
7,608 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2020-05-12 |
4 |
A |
$72.29 |
$260,244 |
I/I |
3,600 |
8,527 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2014-08-12 |
4 |
B |
$69.24 |
$138,480 |
D/D |
2,000 |
9,209 |
2.39 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2015-03-19 |
4 |
D |
$131.21 |
$132,260 |
D/D |
(1,008) |
9,916 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2015-05-08 |
4 |
B |
$6.11 |
$61,100 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Director |
– • – |
2016-05-13 |
4 |
B |
$9.03 |
$90,294 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,551 |
10,551 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2020-05-13 |
4 |
D |
$2.96 |
$25,838 |
D/D |
(8,729) |
10,667 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-15 |
4 |
D |
$15.21 |
$129,696 |
D/D |
(8,527) |
10,911 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2015-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,715 |
10,924 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
